We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+14.94%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$114B
AUM Growth
+$18.7B
Cap. Flow
+$1.27B
Cap. Flow %
1.11%
Top 10 Hldgs %
12.43%
Holding
4,806
New
575
Increased
1,549
Reduced
1,464
Closed
527

Sector Composition

Rank Sector Weight
1 Technology 17.03%
2 Consumer Discretionary 9.51%
3 Healthcare 5.76%
4 Financials 5.47%
5 Communication Services 4.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BGS icon
2876
CALL
B&G Foods
BGS
$298M
$1.2M ﹤0.01%
114,000
+74,000
+185% +$685K
IROHU
2877
DELISTED
Iron Horse Acquisitions Corp Unit
IROHU
$1.2M ﹤0.01%
+119,035
New +$1.19M
PD icon
2878
PagerDuty
PD
$801M
$1.19M ﹤0.01%
51,613
-10,461
-17% -$226K
SPSC icon
2879
SPS Commerce
SPSC
$2.53B
$1.19M ﹤0.01%
6,163
+1,477
+32% +$258K
ADC icon
2880
Agree Realty
ADC
$9.73B
$1.19M ﹤0.01%
18,942
-205,918
-92% -$11.9M
MRTN icon
2881
Marten Transport
MRTN
$1.26B
$1.19M ﹤0.01%
56,704
-80,157
-59% -$1.53M
LXFR icon
2882
Luxfer Holdings
LXFR
$457M
$1.19M ﹤0.01%
133,034
+78,584
+144% +$730K
PERI icon
2883
PUT
Perion Network
PERI
$375M
$1.18M ﹤0.01%
38,300
-1,000
-3% -$28.4K
PHAT icon
2884
Phathom Pharmaceuticals
PHAT
$936M
$1.18M ﹤0.01%
129,389
-1,175
-0.9% -$10.1K
MUFG icon
2885
Mitsubishi UFJ Financial
MUFG
$253B
$1.18M ﹤0.01%
+137,041
New +$1.16M
IWD icon
2886
iShares Russell 1000 Value ETF
IWD
$82.3B
$1.18M ﹤0.01%
+7,137
New +$1.1M
CAKE icon
2887
Cheesecake Factory
CAKE
$4.37B
$1.18M ﹤0.01%
33,678
-31,367
-48% -$1M
FLGT icon
2888
Fulgent Genetics
FLGT
$564M
$1.18M ﹤0.01%
40,695
-2,548
-6% -$68.2K
LFUS icon
2889
Littelfuse
LFUS
$9.67B
$1.18M ﹤0.01%
4,396
+1,329
+43% +$318K
ABR icon
2890
PUT
Arbor Realty Trust
ABR
$977M
$1.17M ﹤0.01%
77,300
AVDX
2891
DELISTED
AvidXchange
AVDX
$1.17M ﹤0.01%
94,642
+2,212
+2% +$22.1K
BLBD icon
2892
Blue Bird Corp
BLBD
$2.32B
$1.17M ﹤0.01%
43,476
-4,362
-9% -$89.8K
BEPC icon
2893
Brookfield Renewable
BEPC
$5.89B
$1.17M ﹤0.01%
40,603
-62,493
-61% -$1.59M
CVAC
2894
DELISTED
CureVac
CVAC
$1.17M ﹤0.01%
+277,538
New +$1.51M
URGN icon
2895
UroGen Pharma
URGN
$2B
$1.17M ﹤0.01%
77,873
+44,240
+132% +$574K
PJT icon
2896
PJT Partners
PJT
$4.32B
$1.17M ﹤0.01%
11,460
+1,654
+17% +$142K
COTY icon
2897
Coty
COTY
$2.46B
$1.17M ﹤0.01%
93,801
-133,977
-59% -$1.45M
SPWR
2898
CALL
DELISTED
SunPower Corporation Common Stock
SPWR
$1.16M ﹤0.01%
+240,700
New +$1.15M
BLND icon
2899
Blend Labs
BLND
$436M
$1.16M ﹤0.01%
455,484
+234,321
+106% +$353K
LEVI icon
2900
PUT
Levi Strauss
LEVI
$9.7B
$1.16M ﹤0.01%
70,000

Similar funds

D.E. Shaw & Co's Q4 2023 Portfolio in Review

As of Q4 2023, D.E. Shaw & Co held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

D.E. Shaw & Co's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • D.E. Shaw & Co's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
  • D.E. Shaw & Co added most to Netflix in Q4 2023, an estimated $751M increase.
  • D.E. Shaw & Co's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
  • D.E. Shaw & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
  • D.E. Shaw & Co's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
  • D.E. Shaw & Co opened 575 new positions and closed 527 in Q4 2023.
  • D.E. Shaw & Co's portfolio value rose 19% quarter-over-quarter to $114B.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.